Arrowhead pharmaceuticals, inc. (ARWR)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Dec'12
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)

9,531

53,263

67,974

45,508

9,566

-29,214

-54,450

-54,421

-44,334

-35,493

-34,380

-45,870

-59,771

-74,544

-81,723

-84,244

-80,759

-88,630

-91,940

-89,628

-85,318

-70,614

-58,725

0

0

0

0

Net loss attributable to non-controlling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-95

0

0

0

0

NET LOSS ATTRIBUTABLE TO ARROWHEAD

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-58,630

0

0

0

0

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Realized and unrealized (gain) loss on investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Charge for bad debt allowance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

(Gain) loss on purchase of Roche Madison

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

(Gain) loss from sale of subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

(Gain) loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

-31

-58

0

0

0

0

Stock issued for professional services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Change in value of derivatives

-

-

-

-

-

-

432

-197

-133

-142

890

985

809

1,206

-301

655

664

463

2,869

2,125

2,988

-131

-6,033

0

0

0

0

Contingent consideration - fair value adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Noncash impairment expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchased in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Stock-based compensation

24,537

14,167

12,393

9,913

10,224

9,079

8,454

7,827

7,272

7,559

7,891

9,929

10,967

11,639

11,595

11,074

10,810

10,598

10,232

8,643

8,196

7,189

5,696

0

0

0

0

Depreciation and amortization

4,717

4,521

4,439

4,585

4,757

4,735

4,699

4,625

4,611

4,646

4,690

4,379

4,035

3,651

3,260

3,272

3,194

2,840

2,336

1,751

1,286

1,232

1,345

0

0

0

0

Amortization/(accretion) of note premiums

-1,158

-1,403

-1,069

-482

-366

-118

-383

0

0

0

-

-

-

-

-231

-2,256

-1,958

-1,349

-1,110

1,322

1,192

1,113

793

0

0

0

0

Gain on sale of stock in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-95

0

0

0

0

Equity in income (loss) of unconsolidated affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in operating assets and liabilities:
Accounts receivable

-12,156

-1,823

333

2,029

13,406

3,018

259

-922

-564

89

-7

0

0

0

-

-

0

0

-

-

-

49

-75

0

0

0

0

Prepaid expenses and other current assets

2,223

2,211

3,710

2,930

2,346

-227

-319

-494

-1,515

-1,758

-2,814

-3,043

-2,120

-496

1,020

0

0

0

-

-

-

-

-

-

-

-

-

Deferred revenue

-87,447

-104,062

82,804

96,997

119,057

156,222

-5,269

-12,964

-20,854

-28,889

157

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accounts payable

9,355

8,264

4,843

2,464

2,251

-1,770

-1,270

-1,067

-787

2,768

-3,509

-2,711

-4,944

-2,350

2,554

1,083

2,606

-660

2,497

2,749

2,502

5,438

1,412

0

0

0

0

Accrued expenses

-633

1,726

2,450

2,192

1,594

77

1,016

283

2,095

-1,101

-401

-1,481

-2,221

1,222

-871

1,862

1,812

1,815

4,435

863

1,760

2,095

3,478

0

0

0

0

Other

2,071

2,323

1,104

-640

-458

-724

-414

-321

-331

4

-274

-158

-198

-147

131

-47

115

3

-40

130

343

316

94

0

0

0

0

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

-26,777

-18,780

173,034

156,544

131,608

135,751

-47,223

-53,746

-49,747

-48,629

-23,938

-24,916

-32,857

-33,279

-64,427

-66,266

-61,033

-62,655

-65,707

-64,607

-61,265

-52,594

-35,416

0

0

0

0

Purchases of property and equipment

18,983

15,583

12,001

4,879

1,854

2,023

1,421

819

1,778

2,756

7,918

10,523

10,012

8,750

3,860

1,982

1,619

1,822

1,970

1,601

1,961

2,156

1,717

0

0

0

0

Proceeds from sale of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

0

0

Purchases of marketable securities

-

-

90,266

95,174

137,331

116,336

52,083

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

46,365

0

0

0

0

Proceeds from sale of marketable securities

61,884

65,869

54,521

38,726

34,604

41,811

46,069

0

0

0

-

-

-

-

17,308

22,987

20,140

26,036

26,090

24,411

18,731

10,599

11,591

0

0

0

0

Other investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Cash paid for acquisitions

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,000

0

0

0

-

-

-

-

-

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

-137,621

29,290

-47,746

-61,328

-104,581

-76,548

-7,434

-14,900

1,027

-41,990

-48,644

-46,137

-23,750

5,557

13,447

21,005

15,520

21,213

14,120

12,820

9,780

-25,835

-36,481

0

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Cash transferred in acquisitions/divestitures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchase of MASA Energy, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Minority equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash paid for interest in Insert

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash obtained from interest in Insert

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payment for patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Principal payments on notes payable

-

-

2,415

2,468

2,521

2,425

208

255

203

348

197

151

206

210

217

216

215

164

213

128

127

273

225

0

0

0

0

Proceeds from the exercises of stock options

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of taxes for net share settled restricted stock unit issuances

-

-

-

-

-

-

-

-

-

-

438

417

417

610

634

0

0

0

-

-

-

-

-

-

-

-

-

Proceeds from the exercises of warrants and stock options

-

-

-

-

-

-

3,631

0

0

0

-

-

-

-

-

-

-

-

504

817

5,212

13,161

12,878

0

0

0

-

Proceeds from sale of stock in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from the issuance of common stock

250,478

250,476

60,521

0

0

0

-

-

-

-

12,419

0

0

0

-

-

-

-

-

-

-

-

172,641

0

0

0

0

Proceeds from issuance of Calando debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

259,411

260,749

66,381

66,119

64,806

119,038

59,953

58,259

56,805

46

12,055

65,821

68,026

67,661

55,131

1,624

-633

-384

290

689

5,084

122,707

185,294

0

0

0

0

NET INCREASE (DECREASE) IN CASH

95,011

271,259

191,670

161,336

91,834

178,241

5,294

-10,387

8,086

-90,574

-60,527

-5,233

11,418

39,940

4,152

-43,636

-46,146

-41,826

-51,296

-51,096

-46,400

44,277

113,396

0

0

0

0

Cash flows from discontinued operations:
Operating cash flows

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Investing cash flows

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Financing cash flows

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash used in discontinued operations:

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Supplementary disclosures:
Interest paid

-

-

27

69

112

156

173

177

180

184

187

144

101

56

11

12

12

13

14

15

16

20

25

0

0

0

0

Property and Equipment expenditures included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Income Taxes Paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0